A single-centered Cohort Study on Favipiravir safety and efficacy in pediatric patients with COVID-19

Conclusion: The administration of favipiravir in pediatrics is associated with higher ADR occurrence in pediatric patients. Also, no positive effect in regard to the need for invasive mechanical ventilation, hospital stay, and the mortality rate was observed.
Source: Iranian Journal of Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research